Capillary Blood Collection Devices Market Size, Share & Trends Analysis Report By Product (Lancets & Micro-container tubes, Micro-hematocrit tubes), By Material, By Application, End Use (Hospitals & Clinics, Blood Donation Centers) By Region, And Segment

Capillary Blood Collection Devices Market Summary

The global capillary blood collection devices market size was estimated at USD 2.09 billion in 2025 and is projected to reach USD 4.14 billion by 2033, growing at a CAGR of 9.51% from 2026 to 2033. Rising availability of PoC diagnostics, increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, & infectious diseases, and various advantages of the product, including frequent blood testing and monitoring, over its alternatives, are some of the primary factors driving the market.

In addition, the higher prevalence of anemia in developing countries is also driving the demand for capillary blood collection devices, as they offer a convenient and accessible blood sampling method. As per World Health Organization estimates, 40% of children aged 6-59 months, 37% of pregnant women, and 30% of women aged 15-49 years globally are suffering from anemia.

Over the past few decades, the prevalence of infectious and non-communicable diseases has significantly increased. Factors such as rapid urbanization, widespread poverty in many developing regions, the rise of antimicrobial resistance, and the growing incidence of foodborne illnesses have contributed to this trend. These dynamics are expected to drive market growth during the forecast period. According to the World Health Organization, noncommunicable diseases (NCDs) are the leading cause of death and disability worldwide, including in Europe, where one in every five men and one in every ten women dies before the age of 70 from illnesses such as cardiovascular disease, cancer, chronic respiratory conditions, and diabetes. Every year, 1.8 million deaths in this region are preventable, with 60% caused by modifiable risk factors such as tobacco use, alcohol use, poor diets, obesity, and a lack of physical activity, and 40% potentially averted by early detection and proper care.

The field of Point-of-Care (PoC) diagnostics has experienced substantial growth in recent years, fueled by advancements in technologies such as biosensors, bioanalytical platforms, innovative assay designs, and other complementary research methodologies. U.S. data from the Population Reference Bureau highlights that the population aged 65 and above is likely to grow twice, from 52 million in 2018 to over 94 million by 2060, which is expected to escalate the demand for PoC diagnostic solutions.

Innovations in molecular diagnostic tools have enabled faster and more cost-effective testing with enhanced convenience. Capillary blood collection devices support rapid hematology tests in conjunction with PoC diagnostics. Compared to venous or arterial blood collection, capillary sampling is less invasive, more affordable, and does not necessitate a trained professional for the procedure.

The growing adoption of rapid PoC diagnostic methods and capillary blood collection devices is predicted to increase further during the forecast period. These devices, when integrated with PoC diagnostic technologies, are particularly suitable for remote and ambulatory healthcare settings. Capillary sampling is frequently used for glucose and hemoglobin testing in clinics and hospitals due to its ease of use and minimally invasive nature. This makes it ideal for home-based testing, further driving market expansion.

In addition, the COVID-19 pandemic significantly influenced the capillary blood collection device industry. The demand for these devices surged as they played a crucial role in testing and monitoring COVID-19 cases, particularly in the use of rapid antigen and antibody tests. Their ease of use and accessibility underscored the need for efficient diagnostic solutions, resulting in wider adoption.

Global Capillary Blood Collection Devices Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the allergy diagnostics & therapeutics market on the basis of product, material, application, End Use, region:

• Product Method Outlook (Revenue, USD Million, 2021 - 2033)
• Lancets
• Micro-container tubes
• Micro-hematocrit tubes
• Warming devices
• Others
• Material Outlook (Revenue, USD Million, 2021 - 2033)
• Plastic
• Glass
• Stainless steel
• Ceramic
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Whole Blood
• Plasma/ serum protein Tests
• Comprehensive metabolic panel tests
• Liver panel/ liver profile/ liver function tests
• Dried blood spot tests
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals and Clinics
• Blood Donation Centers
• Diagnostic Centers
• Home Diagnosis
• Pathology Laboratories
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• South Korea
• Latin America
• Brazil
• Argentina
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Please note The report will be delivered in 2-3 business days upon order notification. Show more